Dr. Joaquin Cagliani, MD, PhD - NYU - Resident Physician

Dr. Joaquin Cagliani

MD, PhD

NYU

Resident Physician

Mineola, NEW YORK | United States

Main Specialties: Anesthesiology, Critical Care Medicine, Surgical Critical Care

Additional Specialties: Shock, Immunology, Molecular Medicine

ORCID logohttps://orcid.org/0000-0001-5448-5195


Top Author

Dr. Joaquin Cagliani, MD, PhD - NYU - Resident Physician

Dr. Joaquin Cagliani

MD, PhD

Introduction

Primary Affiliation: NYU - Mineola, NEW YORK , United States

Specialties:

Additional Specialties:

Education

May 2019
The Feinstein Institute for Medical Research
PhD
Molecular Medicine
Jul 2015 - Feb 2016
Northwell Health

Surgery
Dec 2014
Universidad de Buenos Aires
MD

Experience

Jul 2019
Resident Physician
PGY 1

Publications

9Publications

316Reads

93Profile Views

7PubMed Central Citations

Maximizing the Use of Scoring Systems in the Prediction of Outcomes in Acute Pancreatitis.

Digestion 2019 18;99(2):166-171. Epub 2018 Sep 18.

Pancreas Disease Center, Northwell Health, Great Neck, New York,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000490887DOI Listing
August 2019
12 Reads
2.032 Impact Factor

Incidence, risk factors, and outcomes related with neurological events after liver transplantation in adult and pediatric recipients.

Pediatr Transplant 2018 05 7;22(3):e13159. Epub 2018 Feb 7.

Hepatology and Liver Transplant Unit, Hospital Universitario Austral, Universidad Austral, Pilar, Argentina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/petr.13159DOI Listing
May 2018
69 Reads
1.630 Impact Factor

Deficiency in cold-inducible RNA-binding protein attenuates acute respiratory distress syndrome induced by intestinal ischemia-reperfusion.

Surgery 2017 10 11;162(4):917-927. Epub 2017 Jul 11.

Department of Surgery, Hofstra Northwell School of Medicine, Manhasset, NY; Center for Immunology and Inflammation, The Feinstein Institute for Medical Research, Manhasset, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.surg.2017.06.004DOI Listing
October 2017
22 Reads
3.380 Impact Factor

Immunomodulation by Mesenchymal Stromal Cells and Their Clinical Applications.

J Stem Cell Regen Biol 2017 10;3(2). Epub 2017 Apr 10.

Pancreas Disease Center, Department of Surgery, Northwell Health System, Manhasset, NY, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667922PMC
http://dx.doi.org/10.15436/2471-0598.17.022DOI Listing
April 2017
12 Reads
4 Citations

Bleeding Risk and Thromboprophylaxis in Neurosurgical Patients after Emergency Procedures

J Intensive & Crit Care 2017, 3:1

Journal of Intensive and Critical Care

Purpose: We aimed to evaluate its safety in the emergency neurosurgical population at a tertiary hospital center. Methods: Retrospective analyses of prospectively-collected data were performed on patients ad-mitted to the surgical intensive care unit (SICU) after emergency neurosurgical procedure. We examined patient demographic and clinical information, survival outcomes, and rates of heparin induced thrombocytopenia and pulmonary embolism in patients who received subcutaneous unfractionated heparin (SCUFH) compared to those who did not. Results: We identified 223 emergency neurosurgical patients, of which 100 received no anticoagulation (44.84%) and 123 received SCUFH (55.16%). In the SCUFH group, 88 patients received chemoprophylaxis within 24 h and 35 after 24 h. A statistically significant difference was noted with the admission APACHE II score of patients receiving SCUFH to those who did not, but APACHE III and SAPS on admission were shown to have no difference in outcome. Conclusion: Administration of SCUFH in the emergency neurosurgical population does not increase the risk of bleeding post-operatively and continues to be a safe and effective chemoprophylaxis agent against VTE.

View Article
February 2017
3 Reads

Glycated Hemoglobin, Plasma Glucose, and Erythrocyte Aging.

J Diabetes Sci Technol 2016 11 1;10(6):1303-1307. Epub 2016 Nov 1.

Pancreas Disease Center, Department of Surgery, Northwell Health System, Manhasset, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1932296816659885DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094338PMC
November 2016
22 Reads
1 Citation

Identifying patients at higher risk of hepatocellular carcinoma recurrence after liver transplantation in a multicenter cohort study from Argentina.

Eur J Gastroenterol Hepatol 2016 Apr;28(4):421-7

aHepatology and Liver Transplant Unit, Hospital Universitario Austral bLiver Transplant Unit, Hospital Italiano de Buenos Aires cLiver Transplant Unit, Hospital Alemán, Buenos Aires dSchool of Medicine, University of Buenos Aires, Buenos Aires eLiver Transplant Unit, Hospital Allende, Córdoba, Argentina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0000000000000551DOI Listing
April 2016
68 Reads
1 Citation
2.152 Impact Factor

Followers